Effect of the TNF- inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET
The Clinical Respiratory Journal,

Milman N et al. – In sarcoidosis, treatment with adalimumab can reduce disease activity, as assessed by FDG–PET.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore